Elzasonan

DB18969InvestigationalSmall molecule

Elzasonan is under investigation in clinical trial NCT00275197 (A Research Study to Compare the Treatments of a Combination of Elzasonan With Zoloft, to Zoloft Alone, or Placebo in People With...

Mechanism: Pharmacologically active on 5-hydroxytryptamine receptor 1B
Curator reviewed
Formula / weight: C₂₂H₂₃Cl₂N₃OS · 448.41 g/mol (avg)
Also known as: (2z)-4-(3,4-dichlorphenyl)-2-(2-(4-methylpiperazin-1-yl)benzylidene)thiomorpholin-3-one · 3-thiomorpholinone, 4-(3,4-dichlorphenyl)-2-((2-(4-methyl-1-piperazinyl) phenyl)methylene)-, (2z)-

Resolves to

Compound

UNII933PJL964RCAS361343-19-3ChEMBLCHEMBL3185463

Structure

InChIKeyLHYMPSWMHXUWSK-STZFKDTASA-NSMILESCN1CCN(CC1)C1=CC=CC=C1\C=C1/SCCN(C1=O)C1=CC=C(Cl)C(Cl)=C1

Targets

P28222HTR1B

What you can answer from here — as of July 09, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Elzasonan, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account